Compounds > paclitaxel
Page last updated: 2024-08-23

paclitaxel and metallothionein

paclitaxel has been researched along with metallothionein in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deisseroth, AB; Hanania, EG1
Colangelo, D; Mahboobi, H; Osella, D; Viarengo, A1
Apostoli, P; Beggiolin, G; Beretta, GL; Carenini, N; Colangelo, D; Corna, E; Dal Bo, L; Gatti, L; Leone, R; Lombardi, L; Perego, P; Piazzoni, L; Righetti, SC; Tinelli, S; Zunino, F1
Kaplenko, I; Spaczyński, M; Surowiak, P; Zabel, M1

Other Studies

4 other study(ies) available for paclitaxel and metallothionein

ArticleYear
Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Cells; Chemoprevention; Disease Models, Animal; DNA, Complementary; Drug Resistance, Neoplasm; Female; Genetic Therapy; Humans; Mammary Neoplasms, Animal; Metallothionein; Mice; Mice, Inbred BALB C; Paclitaxel; Promoter Regions, Genetic; Retroviridae; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1997
Effect of metal-based anticancer drugs on wild type and metallothionein null cell lines.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2003, Volume: 16, Issue:3

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cadmium Chloride; Carboplatin; Cell Division; Cell Line; Chlorides; Cisplatin; Copper Sulfate; Deoxycytidine; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Ferrous Compounds; Fibroblasts; Gemcitabine; Inhibitory Concentration 50; Metallothionein; Metals, Heavy; Mice; Mice, Knockout; Paclitaxel; Spectrophotometry, Atomic; Survival Analysis; Survival Rate; Vinblastine; Zinc Compounds

2003
Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.
    International journal of cancer, 2003, Jul-10, Volume: 105, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Base Pair Mismatch; Carmustine; Checkpoint Kinase 1; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Adducts; DNA Damage; DNA Repair; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; G1 Phase; Glutathione; Humans; Melphalan; Metallothionein; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Protein Kinases; Tumor Cells, Cultured

2003
The expression of metallothionein (MT) and proliferation intensity in ovarian cancers treated with cisplatin and paclitaxel.
    Folia morphologica, 2003, Volume: 62, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Count; Cell Division; Cisplatin; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Metallothionein; Ovarian Neoplasms; Paclitaxel; Proliferating Cell Nuclear Antigen

2003